​

Xylem (XYL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

XYL Stock Forecast

Xylem stock forecast is as follows: an average price target of $167.50 (represents a 42.99% upside from XYL’s last price of $117.14) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.

XYL Price Target

The average price target for Xylem (XYL) is $167.50 based on 1-year price targets from 14 Wall Street analysts in the past 3 months, with a price target range of $170.00 to $165.00. This represents a potential 42.99% upside from XYL's last price of $117.14.

XYL Analyst Ratings

Buy

According to 14 Wall Street analysts, Xylem's rating consensus is 'Buy'. The analyst rating breakdown for XYL stock is 0 'Strong Buy' (0.00%), 9 'Buy' (64.29%), 4 'Hold' (28.57%), 1 'Sell' (7.14%), and 0 'Strong Sell' (0.00%).

Xylem Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 13, 2024Damian KarasUBS$165.00$127.5029.41%40.86%
Jul 31, 2024Michael HalloranRobert W. Baird$170.00$133.4827.36%45.13%
May 31, 2024Bryan BlairOppenheimer$152.00$139.409.04%29.76%
May 29, 2024John EadeArgus Research$165.00$140.3617.55%40.86%
May 03, 2024Brett LinzeyMizuho Securities$135.00$135.99-0.73%15.25%
May 03, 2024Deane DrayRBC Capital$162.00$135.9919.13%38.30%
May 03, 2024Michael HalloranRobert W. Baird$155.00$135.9913.98%32.32%
Apr 08, 2024Brad HewittWolfe Research$143.00$128.2711.48%22.08%
Apr 04, 2024Deane DrayRBC Capital$153.00$127.2520.24%30.61%
Aug 18, 2023Nathan JonesStifel Nicolaus$133.00$99.8033.27%13.54%
Feb 08, 2023Citigroup$121.00$106.8513.24%3.30%
Dec 09, 2022Citigroup$123.00$111.2310.58%5.00%
Nov 16, 2022Richard RadbourneAtlantic Equities$129.00$112.1315.05%10.12%
Nov 22, 2021Scott GrahamLoop Capital Markets$120.00$127.19-5.65%2.44%
Nov 12, 2021John EadeArgus Research$150.00$129.8215.54%28.05%
Aug 04, 2021Andrew KaplowitzCitigroup$131.00$125.704.22%11.83%
May 05, 2021Brian K. LeeGoldman Sachs$107.00$116.20-7.92%-8.66%

The latest Xylem stock forecast, released on Aug 13, 2024 by Damian Karas from UBS, set a price target of $165.00, which represents a 29.41% increase from the stock price at the time of the forecast ($127.50), and a 40.86% increase from XYL last price ($117.14).

Xylem Price Target by Period

1M3M12M
# Anlaysts--9
Avg Price Target--$155.56
Last Closing Price$117.14$117.14$117.14
Upside/Downside-100.00%-100.00%32.80%

In the current month, the average price target of Xylem stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Xylem's last price of $117.14. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 09, 2024CitigroupNeutralBuyUpgrade
Nov 06, 2024Cowen & Co.HoldHoldHold
Sep 03, 2024Cowen & Co.BuyHoldDowngrade
Aug 13, 2024UBSBuyInitialise
Jun 05, 2024Cowen & Co.BuyBuyHold
May 31, 2024OppenheimerOutperformOutperformHold
May 28, 2024RBC CapitalOutperformOutperformHold
May 03, 2024RBC CapitalOutperformOutperformHold
Apr 08, 2024CitigroupNeutralNeutralHold
Apr 08, 2024Wolfe ResearchOutperformOutperformHold
Apr 04, 2024RBC CapitalOutperformOutperformHold
Nov 21, 2023Deutsche BankBuyUpgrade
Oct 19, 2023OppenheimerOutperformUpgrade
Oct 09, 2023CitigroupNeutralNeutralHold
Oct 02, 2023NeedhamHoldInitialise
Oct 02, 2023Evercore ISIOutperformUpgrade
Oct 02, 2023Piper SandlerOverweightUpgrade
Oct 02, 2023Keefe, Bruyette & WoodsMarket PerformDowngrade
Oct 02, 2023Goldman SachsOutperformSellDowngrade
May 31, 2023Goldman SachsOutperformUpgrade
Feb 08, 2023CitigroupNeutralNeutralHold
Jan 04, 2023Raymond JamesUnderperformDowngrade
Dec 09, 2022CitigroupNeutralNeutralHold
Nov 16, 2022Atlantic EquitiesOverweightUpgrade
Oct 18, 2022Cowen & Co.Market PerformOutperformUpgrade
Aug 29, 2022Cowen & Co.Market PerformMarket PerformHold
Aug 03, 2022Credit SuisseNeutralUpgrade
Jun 01, 2022Cowen & Co.Market PerformUpgrade

Xylem's last stock rating was published by Citigroup on Dec 09, 2024. The company Upgrade its XYL rating from "Neutral" to "Buy".

Xylem Financial Forecast

Xylem Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue----------------$2.12B-$1.72B$1.45B$1.51B$1.38B$1.36B$1.27B$1.32B$1.26B$1.35B$1.26B$1.37B$1.22B
Avg Forecast$2.51B$2.40B$2.47B$2.32B$2.43B$2.34B$2.39B$2.23B$2.32B$2.23B$2.26B$2.11B$2.18B$2.17B$2.14B$2.00B$2.05B$1.99B$1.49B$1.35B$1.41B$1.34B$1.32B$1.24B$1.31B$1.29B$1.31B$1.17B$1.29B$1.16B
High Forecast$2.54B$2.43B$2.50B$2.35B$2.46B$2.36B$2.42B$2.26B$2.34B$2.26B$2.28B$2.12B$2.20B$2.17B$2.14B$2.00B$2.07B$2.04B$1.51B$1.36B$1.43B$1.34B$1.32B$1.24B$1.31B$1.29B$1.31B$1.17B$1.29B$1.16B
Low Forecast$2.47B$2.37B$2.44B$2.29B$2.40B$2.30B$2.36B$2.20B$2.28B$2.20B$2.23B$2.09B$2.16B$2.17B$2.14B$2.00B$2.03B$1.93B$1.47B$1.33B$1.39B$1.34B$1.32B$1.24B$1.31B$1.29B$1.31B$1.17B$1.29B$1.16B
# Analysts545454544348126336136655511121110999
Surprise %----------------1.03%-1.16%1.08%1.07%1.03%1.04%1.03%1.01%0.98%1.03%1.07%1.06%1.05%

Xylem's average Quarter revenue forecast for Mar 24 based on 3 analysts is $2.00B, with a low forecast of $2.00B, and a high forecast of $2.00B. XYL's average Quarter revenue forecast represents a -5.76% decrease compared to the company's last Quarter revenue of $2.12B (Dec 23).

Xylem EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts545454544348126336136655511121110999
EBITDA----------------$266.00M$152.00M$246.00M$203.00M$269.00M$102.00M$215.00M$168.00M$198.00M$216.00M$221.00M$197.00M$241.00M$135.00M
Avg Forecast$395.16M$378.18M$390.04M$365.61M$383.64M$368.31M$377.16M$351.58M$365.29M$351.60M$355.93M$332.98M$344.53M$342.15M$338.16M$148.17M$323.81M$313.79M$234.60M$134.70M$210.66M$211.97M$208.04M$122.45M$207.29M$203.92M$207.76M$114.05M$204.18M$183.32M
High Forecast$399.83M$382.64M$394.65M$369.93M$388.18M$372.67M$381.61M$355.73M$369.61M$355.76M$360.14M$334.57M$347.69M$342.69M$338.16M$177.80M$326.97M$321.69M$237.37M$161.64M$252.79M$211.97M$208.04M$146.94M$207.29M$203.92M$207.76M$136.86M$204.18M$183.32M
Low Forecast$389.75M$373.00M$384.71M$360.61M$378.40M$363.28M$372.00M$346.77M$360.29M$346.79M$351.06M$329.81M$341.37M$341.62M$338.16M$118.53M$320.66M$304.63M$231.39M$107.76M$168.53M$211.97M$208.04M$97.96M$207.29M$203.92M$207.76M$91.24M$204.18M$183.32M
Surprise %----------------0.82%0.48%1.05%1.51%1.28%0.48%1.03%1.37%0.96%1.06%1.06%1.73%1.18%0.74%

3 analysts predict XYL's average Quarter EBITDA for Mar 24 to be $148.17M, with a high of $177.80M and a low of $118.53M. This is -44.30% lower than Xylem's previous annual EBITDA (Dec 23) of $266.00M.

Xylem Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts545454544348126336136655511121110999
Net Income----------------$266.00M$152.00M$92.00M$99.00M$149.00M$12.00M$112.00M$82.00M$113.00M$114.00M$113.00M$87.00M$148.00M$37.00M
Avg Forecast$363.46M$349.39M$351.07M$300.81M$347.74M$334.08M$326.17M$277.11M$314.19M$298.02M$290.67M$248.25M$275.35M$270.37M$256.37M$87.41M$232.90M$215.95M$198.93M$79.46M$120.22M$160.65M$130.92M$72.24M$149.40M$144.12M$152.36M$50.37M$167.33M$123.16M
High Forecast$369.04M$354.76M$356.47M$305.43M$353.08M$339.22M$331.18M$281.37M$319.02M$302.60M$295.14M$258.09M$277.78M$270.51M$256.40M$104.89M$242.60M$223.22M$201.98M$95.35M$144.27M$160.65M$130.92M$86.69M$149.40M$144.12M$152.36M$60.44M$167.33M$123.16M
Low Forecast$357.00M$343.18M$344.83M$295.46M$341.56M$328.15M$320.37M$272.18M$308.61M$292.72M$285.51M$238.42M$272.91M$270.22M$256.34M$69.93M$223.19M$208.67M$195.39M$63.57M$96.18M$160.65M$130.92M$57.79M$149.40M$144.12M$152.36M$40.29M$167.33M$123.16M
Surprise %----------------1.14%0.70%0.46%1.25%1.24%0.07%0.86%1.14%0.76%0.79%0.74%1.73%0.88%0.30%

Xylem's average Quarter net income forecast for Mar 24 is $87.41M, with a range of $69.93M to $104.89M. XYL's average Quarter net income forecast represents a -67.14% decrease compared to the company's last Quarter net income of $266.00M (Dec 23).

Xylem SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts545454544348126336136655511121110999
SG&A------------------$446.00M$354.00M$315.00M$294.00M$314.00M$304.00M$301.00M$273.00M$304.00M$301.00M$292.00M$266.00M
Avg Forecast$572.74M$548.13M$565.32M$529.92M$556.05M$533.83M$546.65M$509.58M$529.45M$509.61M$515.88M$482.63M$499.36M$495.91M$490.12M$324.05M$469.34M$454.81M$340.03M$294.59M$320.24M$306.36M$300.69M$267.81M$299.61M$294.73M$300.28M$174.26M$295.10M$264.96M
High Forecast$579.51M$554.60M$572.00M$536.18M$562.62M$540.14M$553.11M$515.60M$535.71M$515.63M$521.98M$484.92M$503.94M$496.69M$490.12M$388.86M$473.91M$466.25M$344.05M$353.51M$384.29M$306.36M$300.69M$321.37M$299.61M$294.73M$300.28M$209.12M$295.10M$264.96M
Low Forecast$564.91M$540.63M$557.59M$522.67M$548.44M$526.53M$539.17M$502.61M$522.21M$502.64M$508.83M$478.03M$494.78M$495.14M$490.12M$259.24M$464.76M$441.52M$335.38M$235.67M$256.20M$306.36M$300.69M$214.25M$299.61M$294.73M$300.28M$139.41M$295.10M$264.96M
Surprise %------------------1.31%1.20%0.98%0.96%1.04%1.14%1.00%0.93%1.01%1.73%0.99%1.00%

Xylem's average Quarter SG&A projection for Sep 23 is $454.81M, based on 13 Wall Street analysts, with a range of $441.52M to $466.25M. The forecast indicates a 1.98% rise compared to XYL last annual SG&A of $446.00M (Jun 23).

Xylem EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts545454544348126336136655511121110999
EPS----------------$1.10-$0.45$0.55$0.83$0.07$0.62$0.45$0.63$0.63$0.63$0.49$0.82$0.20
Avg Forecast$1.49$1.43$1.44$1.23$1.43$1.37$1.34$1.14$1.29$1.22$1.19$1.02$1.13$1.11$1.05$0.84$0.96$0.89$0.82$0.62$0.79$0.66$0.54$0.41$0.61$0.59$0.63$0.38$0.69$0.51
High Forecast$1.51$1.46$1.46$1.25$1.45$1.39$1.36$1.15$1.31$1.24$1.21$1.06$1.14$1.11$1.05$0.84$1.00$0.92$0.83$0.63$0.81$0.66$0.54$0.41$0.61$0.59$0.63$0.38$0.69$0.51
Low Forecast$1.46$1.41$1.41$1.21$1.40$1.35$1.31$1.12$1.27$1.20$1.17$0.98$1.12$1.11$1.05$0.84$0.92$0.86$0.80$0.61$0.78$0.66$0.54$0.41$0.61$0.59$0.63$0.38$0.69$0.51
Surprise %----------------1.15%0.00%0.55%0.89%1.05%0.11%1.15%1.09%1.03%1.06%1.01%1.31%1.19%0.40%

According to 3 Wall Street analysts, Xylem's projected average Quarter EPS for Mar 24 is $0.84, with a low estimate of $0.84 and a high estimate of $0.84. This represents a -23.77% decrease compared to XYL previous annual EPS of $1.10 (Dec 23).

Xylem Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
XYLXylem$120.77$167.5038.69%Buy
AOSA. O. Smith$70.81$85.8021.17%Buy
FELEFranklin Electric$103.99$120.0015.40%Buy
DOVDover$196.54$212.638.19%Buy
EMREmerson Electric$128.08$136.756.77%Buy
ITTITT$149.06$159.006.67%Buy
ETNEaton$347.08$370.006.60%Buy
IEXIDEX$222.19$232.004.42%Buy
PHParker-Hannifin$665.99$690.333.65%Buy
IRIngersoll Rand$97.55$101.003.54%Buy
PNRPentair$105.49$107.802.19%Buy
FLSFlowserve$59.83$60.200.62%Buy
ITWIllinois Tool Works$267.88$255.67-4.56%Hold

XYL Forecast FAQ

Is Xylem a good buy?

Yes, according to 14 Wall Street analysts, Xylem (XYL) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 64.29% of XYL's total ratings.

What is XYL's price target?

Xylem (XYL) average price target is $167.5 with a range of $165 to $170, implying a 42.99% from its last price of $117.14. The data is based on 14 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Xylem stock go up soon?

According to Wall Street analysts' prediction for XYL stock, the company can go up by 42.99% (from the last price of $117.14 to the average price target of $167.5), up by 45.13% based on the highest stock price target, and up by 40.86% based on the lowest stock price target.

Can Xylem stock reach $200?

XYL's average twelve months analyst stock price target of $167.5 does not support the claim that Xylem can reach $200 in the near future.

What are Xylem's analysts' financial forecasts?

Xylem's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $9.39B (high $9.5B, low $9.26B), average EBITDA is $1.48B (high $1.5B, low $1.46B), average net income is $1.29B (high $1.3B, low $1.26B), average SG&A $2.15B (high $2.17B, low $2.12B), and average EPS is $5.27 (high $5.35, low $5.18). XYL's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $9.7B (high $9.81B, low $9.56B), average EBITDA is $1.53B (high $1.55B, low $1.51B), average net income is $1.36B (high $1.39B, low $1.34B), average SG&A $2.22B (high $2.24B, low $2.19B), and average EPS is $5.6 (high $5.68, low $5.5).

Did the XYL's actual financial results beat the analysts' financial forecasts?

Based on Xylem's last annual report (Dec 2023), the company's revenue was $7.36B, beating the average analysts forecast of $6.88B by 7.07%. Apple's EBITDA was $1.16B, beating the average prediction of $1.01B by 15.60%. The company's net income was $609M, missing the average estimation of $727.23M by -16.26%. Apple's SG&A was $1.76B, beating the average forecast of $1.56B by 12.72%. Lastly, the company's EPS was $2.79, missing the average prediction of $3.28 by -14.83%. In terms of the last quarterly report (Dec 2023), Xylem's revenue was $2.12B, beating the average analysts' forecast of $2.05B by 3.14%. The company's EBITDA was $266M, missing the average prediction of $323.81M by -17.85%. Xylem's net income was $266M, beating the average estimation of $232.9M by 14.21%. The company's SG&A was $0, missing the average forecast of $469.34M by -100.00%. Lastly, the company's EPS was $1.1, beating the average prediction of $0.955 by 15.13%